Inhibitor of granulopoiesis in human cyclic neutropenia.
Peripheral blood mononuclear cells of a patient with cyclic neutropenia release a high molecular weight substance (over 300,000) inhibiting normal CFU-GM cells to enter the S-phase of cell cycle. The inhibitor was released predominantly in the neutropenic phase of the disease, while in the period of normal granulocyte count the release was lower or undetectable. Also sensitivity of patient's bone marrow CFU-GM cells to similar high molecular weight inhibitor produced by ML-2 cell liner or to human placental ferritin varied within the disease cycle. CFU-GM in the normal granulocyte count period were sensitive to the inhibitors, but CFU-GM in the neutropenic phase were resistant.
Cukrová
V
V
Institute of Haematology and Blood Transfusion, Prague, CSFR.
Klamová
H
H
D000328:Adult; D002453:Cell Cycle; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D005293:Ferritins / Q000494:pharmacology; D006098:Granulocytes / Q000166:cytology / Q000187:drug effects / Q000473:pathology*; D006410:Hematopoiesis; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000097:blood* / Q000503:physiopathology; D012016:Reference Values
D005293:Ferritins